Urol. praxi. 2017;18(2):81-84

New prevention strategies of papillomavirus infections

RNDr. Jana Šmahelová1, 2, RNDr. Eva Hamšíková1, RNDr. Ruth Tachezy, Ph.D.1, 2
1Národní referenční laboratoř pro papillomaviry a polyomaviry, Oddělení imunologie, Ústav hematologie a krevní transfuze, Praha, 2Katedra genetiky a mikrobiologie, Přírodovědecká fakulta, Univerzita Karlova, Praha

Human papillomavirus which infect mostly mucosa are casual agents of cervical carcinoma and a part of a number of other male

and female malignancies as well as number of benign manifestations. The authors summarize current available possibilities and

prevention strategies of HPV infections and its clinical consequences, mostly new possibilities in prophylactic vaccination and in

secondary prevention.

Keywords: human papillomavirus, vaccination, prevention

Published: May 1, 2017  Show citation

ACS AIP APA ASA Harvard Chicago Chicago Notes IEEE ISO690 MLA NLM Turabian Vancouver
Šmahelová J, Hamšíková E, Tachezy R. New prevention strategies of papillomavirus infections. Urol. praxi. 2017;18(2):81-84.
Share...
Download citation
  • BibTeX (.bib)
  • Bookends (.ris)
  • EasyBib (.ris)
  • EndNote (.enw)
  • EndNote 8 (.xml)
  • ISI WoS (.isi)
  • Medlars (.medlars)
  • Mendeley (.ris)
  • MODS (.xml)
  • Papers (.ris)
  • RefWorks (.txt)
  • RefManager (.ris)
  • RIS (.ris)
  • MS Word (.xml)
  • Zotero (.ris)
    • Open full article

    References

    1. Plummer M, de Martel C, Vignat J, et al. Global burden of cancers attributable to infections in 2012: a synthetic analysis. Lancet Glob Health. 2016; 4(9): e609-616. Go to original source... Go to PubMed...
    2. Tachezy R, Smahelova J, Kaspirkova J, et al. Human papillomavirus type-specific prevalence in the cervical cancer screening population of Czech women. PLoS One. 2013; 8(11): e79156. Go to original source... Go to PubMed...
    3. Giuliano AR, Lazcano-Ponce E, Villa LL, et al. The human papillomavirus infection in men study: human papillomavirus prevalence and type distribution among men residing in Brazil, Mexico, and the United States. Cancer Epidemiol Biomarkers Prev. 2008; 17(8): 2036-2043. Go to original source...
    4. Vaccarella S, Franceschi S, Herrero R, et al. IARC HPV Prevalence Surveys Study Group. Sexual behavior, condom use, and human papillomavirus: pooled analysis of the IARC human papillomavirus prevalence surveys. Cancer Epidemiol Biomarkers Prev. 2006; 15(2): 326-333. Go to original source...
    5. Harper DM, Demars LR. Primary strategies for HPV infection and cervical cancer prevention. Clin Obstet Gynecol. 2014; 57(2): 256-278. Review. Go to original source...
    6. Plummer M, Peto J, Franceschi S; International Collaboration of Epidemiological Studies of Cervical Cancer. Time since first sexual intercourse and the risk of cervical cancer. Int J Cancer. 2012; 130(11): 2638-2644. Go to original source...
    7. Weiss P, Zvěřina J. Sexuální chování české populace. Urolog pro Praxi. 2009; 10(3): 160-163.
    8. Hamsikova E, Ludvikova V, Stasikova J, et al. Cross-sectional study on the prevalence of HPV antibodies in the general population of the Czech Republic. Sex Transm Infect. 2013; 89(2): 133-137. Go to original source... Go to PubMed...
    9. Vaccarella S, Herrero R, Snijders PJ, et al. IARC HPV Prevalence Surveys (IHPS) Study Group. Smoking and human papillomavirus infection: pooled analysis of the International Agency for Research on Cancer HPV Prevalence Surveys. Int J Epidemiol. 2008; 37(3): 536-546. Go to original source...
    10. Daling JR, Madeleine MM, Johnson LG, et al. Human papillomavirus, smoking, and sexual practices in the etiology of anal cancer. Cancer 2004; 101: 270-280. Go to original source... Go to PubMed...
    11. Hogewoning CJ, Bleeker MC, van den Brule AJ, et al. Condom use promotes regression of cervical intraepithelial neoplasia and clearance of human papillomavirus: a randomized clinical trial. Int J Cancer. 2003; 107(5): 811-816. Go to original source...
    12. Bleeker MC, Hogewoning CJ, Voorhorst FJ, et al. Condom use promotes regression of human papillomavirus-associated penile lesions in male sexual partners of women with cervical intraepithelial neoplasia. Int J Cancer. 2003; 107(5): 804-810. Go to original source...
    13. Rehmeyer CJ. Male circumcision and human papillomavirus studies reviewed by infection stage and virus type. J Am Osteopath Assoc. 2011; 111(3 Suppl 2): S11-8. Review.
    14. Zhu YP, Jia ZW, Dai B, et al. Relationship between circumcision and human papillomavirus infection: a systematic review and meta-analysis. Asian J Androl. 2017; 19(1): 125-131. Go to original source...
    15. Castellsague X, Bosch FX, Munoz N, et al. Male circumcision, penile human papillomavirus infection, and cervical cancer in female partners. N Engl J Med. 2002; 346: 1105-1112. Go to original source...
    16. Stanley M. Perspective: Vaccinate boys, too. Nature 2012; 488: S10. Go to original source... Go to PubMed...
    17. Tachezy R, Smahelova J, Salakova M, et al. Human papillomavirus genotype distribution in Czech women and men with diseases etiologically linked to HPV. PLoS One 2011; 6(7): e21913. Go to original source... Go to PubMed...
    18. Rotnaglova E, Tachezy R, Salakova M, et al. HPV involvement in tonsillar cancer: Prognostic significance and clinically relevant markers. Int J Cancer 2011; 129(1): 101-110. Go to original source...
    19. Novotvary 2011. UZIS CR, NOR CR; 2015 (ISBN 978-80-7472-097-0)
    20. Chow EP, Read TR, Wigan R; et al. Ongoing decline in genital warts among young heterosexuals 7 years after the Australian human papillomavirus (HPV) vaccination programme. Sex Transm Infect 2015; 91: 214-249. Go to original source... Go to PubMed...
    21. Machalek DA, Chow EP, Garland SM, et al. Human papillomavirus prevalence in unvaccinated heterosexual males following a national female vaccination program. J Infect Dis 2016, Nov 4, pii: jiw530 (Epub ahead of print) Go to original source...
    22. Brotherton JM, Fridman M, May CL, et al. Early effect of the HPV vaccination programme on cervical abnormalities in Victoria, Australia: an ecological study. Lancet 2011; 377: 2085-2092. Go to original source...
    23. Baldur-Felskov B, Dehlendorff C, Junge J, et al. Incidence of cervical lesions in Danish women before and after implementation of a national HPV vaccination program. Cancer Causes Control 2014; 25: 915-922. Go to original source...
    24. Drolet M, Benard E, Boily MC, et al. Population-level impact and herd effects following human papillomavirus vaccination programmes: a systematic review and meta-analysis. Lancet Infect Dis 2015; 15: 565-580. Go to original source...
    25. Joura EA, Garland SM, Paavonen J, et al. Effect of the human papillomavirus (HPV) quadrivalent vaccine in a subgroup of women with cervical and vulvar disease: retrospective pooled analysis of trial data. BMJ 2012; 344: e1401 Go to original source... Go to PubMed...
    26. Konsensus pro řešení abnormálních nálezů ve skríningu cervikálních karcinomů I a II. [online] Dostupný na WWW http://www.kolposkopie.eu/files/files/asc+agc_bden12[1].pdf a http://www.kolposkopie.eu/files/files/LSIL,_H_SIL_verze_II.pdf [cit 2017-01-24]
    27. Arbyn M, Snijders PJ, Meijer CJ, et al. Which high-risk HPV assays fulfil criteria for use in primary cervical cancer screening? Clin Microbiol Infect. 2015; 21(9): 817-26. Review. Go to original source...
    28. Machalek DA, Grulich AE, Jin F, et al. The epidemiology and natural history of anal human papillomavirus infection in men who have sex with men. Sex Health. 2012; 9(6): 527-537. Go to original source...
    29. Solomon D, Davey D, Kurman R, et al. Forum Group Members.; Bethesda 2001 Workshop. The 2001 Bethesda System: terminology for reporting results of cervical cytology. JAMA. 2002; 287(16): 2114-2119. Review. Go to original source...
    30. Roberts JM, Ekman D. The reporting of anal cytology and histology samples: establishing terminology and criteria. Sex Health. 2012; 9(6): 562-567. Go to original source...
    31. Jones CM, Goh V, Sebag-Montefiore D, et al. Biomarkers in anal cancer: from biological understanding to stratified treatment. Br J Cancer. 2017; 116(2): 156-162. Go to original source... Go to PubMed...
    32. Chung CH, Bagheri A, D'Souza G. Epidemiology of oral human papillomavirus infection. Oral Oncol. 2014; 50(5): 364-369. Go to original source...
    33. Shigeishi H, Sugiyama M. Risk Factors for Oral Human Papillomavirus Infection in Healthy Individuals: A Systematic Review and Meta-Analysis. J Clin Med Res. 2016; 8(10): 721-729. Go to original source...
    34. Fakhry C, Rosenthal BT, Clark DP, et al. Associations between oral HPV16 infection and cytopathology: evaluation of an oropharyngeal "pap-test equivalent" in high-risk populations. Cancer Prev Res (Phila). 2011; 4: 1378-1384. Go to original source... Go to PubMed...
    35. Franceschi S, Combes JD, Dalstein V, et al. Study of Natural History of Human Papillomavirus Infection and Precancerous Lesions in the Tonsils (SPLIT). Deep brush-based cytology in tonsils resected for benign diseases. Int J Cancer. 2015; 137(12): 2994-2999. Go to original source...
    36. Kreimer AR, Johansson M, Waterboer T, et al. Evaluation of human papillomavirus antibodies and risk of subsequent head and neck cancer. J Clin Oncol. 2013; 31(21): 2708-2715. Go to original source...
    37. Kreimer AR, Brennan P, Lang Kuhs KA, et al. Human papillomavirus antibodies and future risk of anogenital cancer: a nested case-control study in the European prospective investigation into cancer and nutrition study. J Clin Oncol. 2015; 33(8): 877-884. Go to original source... Go to PubMed...

    Return to the content


    Urology for Practice

    Madam, Sir,
    please be aware that the website on which you intend to enter, not the general public because it contains technical information about medicines, including advertisements relating to medicinal products. This information and communication professionals are solely under §2 of the Act n.40/1995 Coll. Is active persons authorized to prescribe or supply (hereinafter expert).
    Take note that if you are not an expert, you run the risk of danger to their health or the health of other persons, if you the obtained information improperly understood or interpreted, and especially advertising which may be part of this site, or whether you used it for self-diagnosis or medical treatment, whether in relation to each other in person or in relation to others.

    I declare:

    1. that I have met the above instruction
    2. I'm an expert within the meaning of the Act n.40/1995 Coll. the regulation of advertising, as amended, and I am aware of the risks that would be a person other than the expert input to these sites exhibited

    No
    Yes

    If your statement is not true, please be aware
    that brings the risk of danger to their health or the health of others.